Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Feline Leukemia Virus Viral Myc Transforming Protein (MYC)

Cat. No.VG2C128

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Feline Leukemia Virus Viral Myc Transforming Protein (MYC) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 9.4 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 9.4 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

Feline leukemia virus viral myc transforming protein (MYC) is a viral oncogene product that contributes to the pathogenesis of FeLV-associated lymphomas and leukemias. It is involved in the transformation of host cells by activating cellular proto-oncogenes, leading to uncontrolled cell proliferation. In veterinary medicine, MYC is used as a biomarker for studying the molecular mechanisms of FeLV-induced cancers and for developing diagnostic tools to detect FeLV infections and associated malignancies. Additionally, understanding MYC's role helps in designing targeted therapies to inhibit viral oncogenesis.

Protein Feline Leukemia Virus Viral Myc Transforming Protein (MYC)
Protein Synonym Viral myc transforming protein
UniProt ID P68272

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket